Reduced mortality rate after coronavac vaccine among healthcare workers.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Longitudinal evaluation of innate immune responses to three doses of CoronaVac vaccine.Frontiers in immunology · 2023
   Article
2. The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.Vaccine · 2022
   Article
3. Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning.Computers in biology and medicine · 2022
   Article
4. Reduced CoronaVac vaccine antibody response in patients with chronic kidney disease.International urology and nephrology · 2022
   Article
5. COVID-19: vaccination vs. hospitalization.Infection · 2022
   Article
6. Determination of COVID-19 PCR positivity and mutation status in coronaVac vaccinated individuals in Turkey.Turkish journal of medical sciences · 2022
   Article
7. Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine.Immunity & ageing : I & A · 2022
   Article
8. Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.The Journal of infection · 2022
   Article
9. The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.Vaccine · 2022
   Article
10. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.Biomedicines · 2021
    Review
11. The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines.Frontiers in medicine · 2021
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as